受强制性开放获取政策约束的文章 - Stefan Fischli了解详情
可在其他位置公开访问的文章：10 篇
A copeptin-based approach in the diagnosis of diabetes insipidus
W Fenske, J Refardt, I Chifu, I Schnyder, B Winzeler, J Drummond, ...
New England Journal of Medicine 379 (5), 428-439, 2018
强制性开放获取政策： Swiss National Science Foundation, German Research Foundation, Federal …
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
TR Pieber, B Bode, A Mertens, YM Cho, E Christiansen, CL Hertz, ...
The lancet Diabetes & endocrinology 7 (7), 528-539, 2019
强制性开放获取政策： US National Institutes of Health
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study
E Christ, D Wild, S Ederer, M Béhé, G Nicolas, ME Caplin, M Brändle, ...
The lancet Diabetes & endocrinology 1 (2), 115-122, 2013
强制性开放获取政策： Swiss National Science Foundation, Cancer Research UK, UK Engineering and …
Dehydroepiandrosterone sulfate in the assessment of the hypothalamic-pituitary-adrenal axis
S Fischli, S Jenni, S Allemann, M Zwahlen, P Diem, ER Christ, C Stettler
The Journal of Clinical Endocrinology & Metabolism 93 (2), 539-542, 2008
强制性开放获取政策： Swiss National Science Foundation
External validation of the GREAT score to predict relapse risk in Graves' disease: results from a multicenter, retrospective study with 741 patients
T Struja, M Kaeslin, F Boesiger, R Jutzi, N Imahorn, A Kutz, L Bernasconi, ...
European journal of endocrinology 176 (4), 413-419, 2017
强制性开放获取政策： Swiss National Science Foundation
Is Graves’ disease a primary immunodeficiency? New immunological perspectives on an endocrine disease
T Struja, A Kutz, S Fischli, C Meier, B Mueller, M Recher, P Schuetz
BMC medicine 15, 1-15, 2017
强制性开放获取政策： Swiss National Science Foundation
Canakinumab in patients with COVID-19 and type 2 diabetes–A multicentre, randomised, double-blind, placebo-controlled trial
M Hepprich, JM Mudry, C Gregoriano, FR Jornayvaz, S Carballo, ...
EClinicalMedicine 53, 2022
强制性开放获取政策： Swiss National Science Foundation
Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma
PJ Eugster, J Maurer, C Vocat, K Abid, M Matter, G Wuerzner, R Trepp, ...
Clinica Chimica Acta 534, 146-155, 2022
强制性开放获取政策： Swiss Cancer League
Personalised immunomodulating treatments for Graves’ disease: fact or fiction?
T Struja, A Kutz, S Fischli, C Meier, B Müller, P Schütz
Swiss medical weekly 147 (3132), w14476-w14476, 2017
强制性开放获取政策： Swiss National Science Foundation
Recurrent hypoglycemia in a case of congenital analbuminemia
M Litzel, G Caridi, F Lugani, M Campagnoli, L Minchiotti, S Fischli
Case Reports in Endocrinology 2020 (1), 8452564, 2020
强制性开放获取政策： Government of Italy
出版信息和资助信息由计算机程序自动确定